DrugPatentWatch.com Premium Plan - Drug patent expiration dates, exclusivity, sales, patent detals, case histories, and more...

DrugPatentWatch - Online Approved Drug Database

This preview contains a fraction of the information available in the subscriber section and is limited to 5 results per search.

Instant Access with secure payment processing:
	$235 / One Month	$975 / One Year

Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Exclusivity Expiration - 2011

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Exclusivity Expiration Patented / Exclusive Use
Alcon PATANASE olopatadine hydrochloride 021861 Apr 15, 2008 Apr 15, 2011 NEW DOSAGE FORM
Glaxosmithkline TREXIMET naproxen sodium; sumatriptan succinate 021926 Apr 15, 2008 Apr 15, 2011 NEW COMBINATION
Ipsen Ltd APOKYN apomorphine hydrochloride 021264 Apr 20, 2004 Apr 20, 2011 ORPHAN DRUG EXCLUSIVITY
Procter And Gamble ACTONEL risedronate sodium 020835 Apr 22, 2008 Apr 22, 2011 NEW STRENGTH
New River Pharms VYVANSE lisdexamfetamine dimesylate 021977 Dec 10, 2007 Apr 23, 2011 NEW PATIENT POPULATION

Complete access available with subscription

2009 2010 2011 2012 2013 2014 2015 2016

Bookmark This Site

Drug Patent Expiration Dates

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek independent professional advice before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

All trademarks and applicant names are the property of their respective owners or licensors.